COVID-19 Rapid Research Response Scientific Advisory Board

Innovative
Genomics
Institute

COVID-19 Rapid Research Response Scientific Advisory Board

This SAB is commissioned with reviewing research projects associated with the IGI’s COVID-19 response.

Board Members

Mike Botchan, Ph.D.

UC Berkeley

Dean of Biological Sciences; Professor of Molecular & Cell Biology; Deputy Director, Innovative Genomics Institute

Bruce Conklin, M.D.

Gladstone Institutes/UCSF

Senior Investigator, Data Science and Biotechnology at the Gladstone Institutes; Professor, Medicine, Ophthalmology, and Pharmacology at UCSF; Deputy Director, Innovative Genomics Institute

Britt Glaunsinger, Ph.D.

UC Berkeley

Professor, Plant & Microbial Biology and Molecular & Cell Biology; Class of 1963 Endowed Chair; HHMI Investigator; IGI Investigator

Professor, Bioethics and Medical Humanities in the UCB-UCSF Joint Medical Program; Class of 1940 Endowed Chair; Co-founder, Berkeley Ethics and Regulation Group for Innovative Technologies; IGI Investigator

Eva Harris, Ph.D.

UC Berkeley

Professor, Infectious Diseases and Vaccinology; Director, Center for Global Public Health; Program Head, Infectious Diseases and Immunity PhD Program; President, Sustainable Sciences Institute

Melanie Ott, M.D., Ph.D.

Gladstone Institutes/UCSF

Senior Investigator, Virology and Immunology at the Gladstone Institutes; Professor, Medicine at UCSF

Julia Schaletzky, Ph.D.

UC Berkeley

Executive Director, Center for Emerging and Neglected Diseases (CEND), Immunotherapy and Vaccine Research Initiative (IVRI), UCB Drug Discovery Center

Jonathan Weissman, Ph.D.

Whitehead Institute/MIT

Landon T. Clay Professor of Biology, Whitehead Institute; Professor, Biology at the Massachusetts Institute of Technology (MIT); HHMI Investigator; Co-Director, Innovative Genomics Institute